Jurgen Sergeys
0000-0002-6418-7359
AbbVie
16 papers found
Refreshing results…
Src kinase inhibition as a potential treatment strategy for diabetic retinopathy and dry age-related macular degeneration?
The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific SRC family kinase inhibition in retinal vascular disease
Age-Dependent Changes in Glucose Homeostasis in Male Deiodinase Type 2 Knockout Zebrafish
A potential role for Src during early experimental diabetic retinopathy?
Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses
Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes
Inhibition of a hyperactive kinase signaling hub as a novel and integrative therapy for diabetic retinopathy
Thorough longitudinal in vivo characterization of the streptozotocin-induced diabetic mouse model
Targeting Transforming Growth Factor beta 2 (TGF-β2) mRNA with ISTH0036 as Novel Therapeutic Intervention in Neovascular Ocular Disease
Unraveling the role of ROCK in neuronal survival and axonal outgrowth in the pathological retina: validation of mouse and pig retinal cell and explant models
MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment
MMP-3 deficiency suppresses endotoxin-induced acute inflammation in the eye
AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy
The impact of senescence on the zebrafish’s neuroregenerative capacities
Optimization of pig and mouse retinal cell and explant models to study the cellular mechanisms of deleterious ROCK signaling in neuronal survival and axonal outgrowth
Validation of in vitro, ex vivo and in vivo glaucoma models to study neuroprotection and axonal regeneration by ROCK inhibitors
Missing publications? Search for publications with a matching author name.